Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
31 participants
INTERVENTIONAL
2009-03-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To prove the safety of the formulation in normal conditions of use.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dermacyd Infantile (Lactic Acid)- Compatibility.
NCT00881374
Dermacyd Infantile (Lactic Acid) - Photo Evaluation.
NCT00881348
Dermacyd PH_DESILSTY_FR (Lactic Acid) - Compatibility - Stay on Frutal
NCT00933907
Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal
NCT00932945
Dermacyd Silver Frutal (Lactic Acid) - Acceptability.
NCT00933413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dermacyd infantile (Lactic Acid)
treatment duration 21 consecutive days
LACTIC ACID(ND)
Dermacyd Infantile (LACTIC ACID)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LACTIC ACID(ND)
Dermacyd Infantile (LACTIC ACID)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Use the same category of cosmetics
* Willingness in following the study procedures and to be present in the clinic at the days and scheduled time.
Exclusion Criteria
* Allergic or atopic history to cosmetics products
* Cutaneous active disease (local or general) in the evaluated area
* Disease which can cause immunosuppressant, such as diabetes, HIV
* Endocrine pathology
* Intensive solar exposure until 15 days before evaluation
* Treatment four months before selection.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanofi
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
sanofi-aventis
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaderson Lima
Role: STUDY_DIRECTOR
Sanofi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sanofi-Aventis Administrative Office
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LACAC_L_04678
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.